 Data on 1021 patients with C2 to C4
disease from 13 RCTs were analyzed. A variety of
compression stocking ranging from 10 to 50 mm Hg had
been used in the studies, and none had reported the QoL
measures used to assess the outcomes. No side effects
were reported. The review concluded that “there is
insufﬁcient high-certainty evidence to determine
whether or not compression